Implants used in dental and orthopaedic surgery should become osseointegrated into native bone. In an endeavour to potentiate bone formation, prostheses, coated with a coprecipitated layer of calcium phosphate and the osteogenic agent BMP-2, were implanted at an ectopic site in rats. Five weeks later, the implants were surrounded by a substantial mass of bone. Our findings indicate that the drug was gradually released. We postulate that the release of BMP-2 from coatings was cell-mediated.
Introduction
The osteoconductivity of metallic implants used in dentistry and orthopaedic surgery can be enhanced by coating their surfaces with a layer of either calcium-phosphate-based or bone-matrix-like material [1, 2] . These inorganic layers are of course three-dimensional lattice works, and, when viewed as such, the idea of exploiting them as a carrier scaffolding for the slow delivery of osteoinductive agents to the peri-implant site appears logical. In a previous study, we pursued this idea by coprecipitating the osteogenic growth factor, BMP-2, and calcium phosphate upon the surfaces of titanium-alloy implants. BMP-2 formed an integral part of the three-dimensional inorganic latticework and was not merely adsorbed upon its surface [3, 4] . Furthermore, the osteogenicity of BMP-2 thus incorporated was not only retained but potentiated in an in vitro system comprised of cultured osteoprogenitor cells [5] . In the present investigation, we wished to evaluate the kinetics and histomorphometry of osteoinduction by BMP-2 thus incorporated in an in vitro system, namely, at an ectopic site in rats.
Materials and methods
One experimental and three control groups were set up: titanium-alloy discs coated with a co-precipitated layer of calcium phosphate and BMP-2 [1.7 Ag per disc (experimental group)]; naked discs (control); discs coated with a layer of pure calcium phosphate (control); and discs coated with a layer of calcium phosphate upon which BMP-2 was superficially adsorbed [0.98 Ag per disc (control)]. Discs (n=6 per group) were implanted subcutaneously in rats and retrieved at 7-day intervals over a period of 5 weeks for kinetic and histomorphometric analyses.
Results and discussion
In the experimental group, osteogenic activity was first observed 2 weeks after implantation and thereafter continued unabated until the end of the monitoring period. The net daily rates of bone formation per disc were 0.83 and 0.52 mm 3 at 2 and 5 weeks, respectively. The total volumes of bone formed per disc at these junctures were 5.8 and 10.3 mm 3 , respectively. Bone, which was formed by an intramembranous mechanism, was deposited at distances of up to 340 Am from the implants. Coatings were degraded gradually, initially by foreign-body giant cells and then, after the first week, also by osteoclasts.
Forty percent of the coating material (and thus presumably of the incorporated BMP-2) remained at the end of the monitoring period, indicating that its osteoinductive potential was not exhausted. At this 5-week juncture, no bone tissue was associated with any of the control implants.
We postulate that during the initial postoperative phase, foreign-body giant cells, in being drawn to the site of implantation as part of the inflammatory response mounted against foreign material, and in embarking on their destructive task by attacking the coating, may actually promote osteogenic activity by liberating BMP-2 from the inorganic matrix as they degrade it. They thus assume the role played by osteoclasts in physiological bone formation and remodelling signalling pathways [6] [7] [8] and in our model after the first week of implantation. Hence, a potentially destructive agency in the system is turned into a constructive one, with the inflammatory reaction being enlisted in the osteogenic response. It could of course be argued that BMP-2 is released spontaneously from the coatings. Indeed, a small amount of the growth factor is known to be liberated in this manner [3] , but the concentration probably lies below the osteoinductive threshold. This surmise is supported by our findings relating to preformed calcium phosphate layers bearing superficially adsorbed BMP-2. These coatings induced only an abortive osteogenic response during the first postoperative week, and the islands of bone formed were so small and so rare as to be quantitatively nonmeasurable; by the second week, this osseous tissue had been completely resorbed.
Conclusion
The biomimetic coprecipitation of BMP-2 and calcium phosphate yields a coating which is highly biocompatible, osteoconductive and osteoinductive. Furthermore, BMP-2 is released not only at a level that suffices to induce osteogenesis, but gradually, perhaps in a cellmediated manner, such that osteogenic activity is sustained for a considerable period of time. In future experiments, this principle will be optimized for application at orthotopic sites.
